Return to homepagePandemic Pact

Stem Cell Derived Exosome Therapy for Clinical Management of Lung Damage in Critically-ill Corona Viral Pneumonia Patients

Grant number: CVD/2020/000224

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    SERB India

  • Principal Investigator

    Dr. Naresh Kasoju

  • Research Location

    India

  • Lead Research Institution

    Sree Chitra Tirunal Institute for Medical Sciences & Technology

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Drug repurposing against key COVID-19 targets

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape.